Compare FLO & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLO | PAHC |
|---|---|---|
| Founded | 1919 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2000 | 2014 |
| Metric | FLO | PAHC |
|---|---|---|
| Price | $6.43 | $34.64 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 3 |
| Target Price | $7.30 | ★ $47.00 |
| AVG Volume (30 Days) | ★ 5.5M | 191.7K |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | ★ 7.45% | 1.46% |
| EPS Growth | N/A | ★ 104.20 |
| EPS | 0.39 | ★ 0.72 |
| Revenue | ★ $5,256,479,000.00 | $833,350,000.00 |
| Revenue This Year | N/A | $4.08 |
| Revenue Next Year | N/A | $3.43 |
| P/E Ratio | ★ $17.24 | $46.35 |
| Revenue Growth | 3.00 | ★ 4.12 |
| 52 Week Low | $5.40 | $28.25 |
| 52 Week High | $12.09 | $60.08 |
| Indicator | FLO | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 51.79 | 41.15 |
| Support Level | $5.74 | $32.97 |
| Resistance Level | $6.44 | $40.69 |
| Average True Range (ATR) | 0.30 | 1.68 |
| MACD | 0.06 | -0.60 |
| Stochastic Oscillator | 45.07 | 23.72 |
Flowers Foods Inc operates as a producer and marketer of packaged bakery foods in the United States. Its principal products include breads, buns, rolls, snack items (bars, cakes, cookies, and crackers), bagels, English muffins, tortillas, and baking mixes. These products are sold under the brand names Nature's Own, Dave's Killer Bread (DKB), Canyon Bakehouse, Simple Mills, Wonder, and Tastykake. The company derives the majority of its revenue from the sales of its bakery products.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.